advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (21)
Showing records 1 to 21
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation59349 Ocular surface alterations and topical antiglaucomatous therapy: a review
Actis AG; Rolle T
Open Ophthalmology Journal 2014; 8: 67-72
59119 The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
Tsumura T; Yoshikawa K; Kimura T; Suzumura H; Kawashima M; Nanno M; Ishijima K; Takeda R
Clinical Ophthalmology 2014; 8: 1681-1687
59238 Intraocular pressure decrease with preservative-free fixed and unfixed combination of tafluprost and timolol in pseudoexfoliative glaucoma
Holló G; Ropo A
Current Medical Research and Opinion 2014; 0: 1-4
59260 Potential drug delivery approaches for XFS-associated and XFS-associated glaucoma
Kulkarni SS; Kompella UB
Journal of Glaucoma 2014; 23: S77-9
59577 Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
Dubiner HB; Hubatsch DA
BMC Ophthalmology 2014; 14: 151
59389 Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models
Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
Current Eye Research 2014; 0: 1-11
59385 Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes
Quinteros D; Vicario-de-la-Torre M; Andrés-Guerrero V; Palma S; Allemandi D; Herrero-Vanrell R; Molina-Martínez IT
PLoS ONE 2014; 9: e110344
59261 Noninvasive ocular drug delivery: potential transcorneal and other alternative delivery routes for therapeutic molecules in glaucoma
Foldvari M
Journal of Glaucoma 2014; 23: S80-2
58908 Mirror-hat device as a drop delivery aid: a pilot study
Strungaru MH; Peck J; Compeau EC; Trope GE; Buys YM
Canadian Journal of Ophthalmology 2014; 49: 333-338
59588 Glaucoma medications, preservatives and the ocular surface
Aptel F; Labbé A; Baudouin C; Bron A; Lachkar Y; Sellem E; Renard JP; Nordmann JP; Rouland JF; Denis P
Journal Français d'Ophtalmologie 2014; 37: 728-736
59114 Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles
Kim YC; Edelhauser HF; Prausnitz MR
Investigative Ophthalmology and Visual Science 2014; 55: 7387-7397
58788 Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clinical and Experimental Ophthalmology 2015; 43: 164-172
59094 Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models
Mohammadi S; Jones L; Gorbet M
PLoS ONE 2014; 9: e106653
59219 Comparison of the ocular surface changes following the use of two different prostaglandin F2α analogues containing benzalkonium chloride or polyquad in rabbit eyes
Lee HJ; Jun RM; Cho MS; Choi KR
Cutaneous and Ocular Toxicology 2014; 0: 1-8
59269 Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives
Tu EY
Saudi Journal of Ophthalmology 2014; 28: 182-187
59089 The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye
Barabino S; Antonelli S; Cimbolini N; Mauro V; Bouzin M
Investigative Ophthalmology and Visual Science 2014; 55: 6499-6504
59551 Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma
Taniguchi EV; Kalout P; Pasquale LR; Kohane DS; Ciolino JB
Therapeutic delivery 2014; 5: 1077-1083
59068 Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clinical and Experimental Ophthalmology 2015; 43: 214-220
59000 Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits
Warsi MH; Anwar M; Garg V; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
Colloids and surfaces. B, Biointerfaces 2014; 122: 423-431
59612 Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit
Leonardi A; Bucolo C; Drago F; Salomone S; Pignatello R
International Journal of Pharmaceutics 2014; 478: 180-186
58798 Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study
Wang F; Chen L; Zhang D; Jiang S; Shi K; Huang Y; Li R; Xu Q
Journal of drug targeting 2014; 22: 849-858